Last Price
15.33
Today's Change
-1.90 (11.02%)
Day's Change
15.28 - 17.45
Trading Volume
795,431
Overview
Market Cap
199 Million
Shares Outstanding
12 Million
Avg Volume
218,200
Avg Price (50 Days)
46.80
Avg Price (200 Days)
39.05
PE Ratio
-4.19
EPS
-3.66
Earnings Announcement
17-Mar-2025
Previous Close
17.23
Open
17.31
Day's Range
15.28 - 17.45
Year Range
12.49 - 74.49
Trading Volume
796,362
Price Change Highlight
1 Day Change
-11.03%
5 Day Change
-60.53%
1 Month Change
-70.89%
3 Month Change
-57.23%
6 Month Change
-52.86%
Ytd Change
-22.85%
1 Year Change
18.29%
3 Year Change
-84.39%
5 Year Change
-76.12%
10 Year Change
-90.49%
Max Change
-93.59%
News and Blogs
No result.
Company Profile
Sector: Healthcare - Healthcare
Industry: Biotechnology
Description:
Neurogene Inc. develops life-changing genetic medicines for patients and their families affected by neurological diseases. Its product candidate includes NGN-401, an investigational AAV9 gene therapy for the treatment of Rett syndrome; and NGN-101 to treat neuronal ceroid lipofuscinosis subtype 5 batten disease. The company is headquartered in New York, New York.
Discussions
Be the first to like this. Showing 0 of 0 comments
Post a Comment
Latest Videos
Apps
Top Articles
1
CEO Morning Brief
US Got the World Driving. Now It’s Going Home — David Fickling
2
CEO Morning Brief
3
CEO Morning Brief
S&P Sees Some Signs of a US Credit Bubble as Spreads Tighten
4
CEO Morning Brief
Boeing to Lay Off Over 2,500 Workers in US as Part of Sweeping Cuts
5
CEO Morning Brief
#
Stock
Score
Daily Stocks
Stock
Last
Change
Volume
Stock
Last
Change
Volume
Stock
Last
Change
Volume
Ride The Bull Short The Bear
CS Tan
4.9 / 5.0
This book is the result of the author's many years of experience and observation throughout his 26 years in the stockbroking industry. It was written for general public to learn to invest based on facts and not on fantasies or hearsay....
